Krystal Biotech's VYJUVEK® Approved in Japan for Dystrophic Epidermolysis Bullosa

Krystal Biotech announced that Japan's Ministry of Health, Labour and Welfare (MHLW) approved VYJUVEK® (beremagene geperpavec-svdt) for treating dystr...